Jean Marc Gurruchaga

Publications

569

Citations

H-Index

2014

Active since

Affiliations

Institut Mondor de Recherche Biomédicale(Current)

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

CEA Paris-Saclay - Etablissement de Fontenay-aux-roses

Addenbrooke's Hospital

Oxford BioMedica (United Kingdom)

Jean Marc Gurruchaga is an author at Institut Mondor de Recherche Biomédicale specializing in pharmacotherapy, clinical trials, and neurodegenerative diseases.

Top concepts

MedicineNeurologyClinical TrialsPharmacotherapyNeurodegenerative DiseasesGene TherapyNeurosciencePharmacologyNeuropathologyRehabilitation

Publications per year

2014–2018

Publications

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11

Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease

Stéphane Palfi, Jean Marc Gurruchaga, H. Lepetit et al. · Human Gene Therapy Clinical Development · 2018 · 137 citations · Full text

Phase I/ii Study, Dopamine Receptors, Pharmacotherapy +16

Rows per page

1–2 of 2